Guo-Wei He

TEDA International Cardiovascular Hospital, Tianjin University, China

Title: Post-Translational Acylation of Proteins in Cardiovascular Diseases

---

Biography

Abstract

Guo-Wei HE, MD, Distinguished Professor of Tianjin University, China and Academician (Foreign Correspondence Member) at The National Academy of Medicine, France (2019-); Vice President & Senior Cardiac Surgeon at TEDA International Cardiovascular Hospital, Tianjin University; Clinical Professor of Surgery at Oregon Health & Science University, Portland, OR, USA (2003-); Director of Tianjin Key Laboratory for Molecular Regulation and Translational Medicine of Cardiovascular Diseases. He obtained Doctor of Science (2003) and Ph. D.(1989) from Monash University, Melbourne, Australia.

He was Chair Professor of Cardiothoracic Surgery, University of Hong Kong, 1995-2000 and Research Chair Professor, Chinese University of Hong Kong (2000-2009). He was Director of Cardiovasc Res Lab, St, Vincent Hospital, Portland, OR, U.S.A. (1994-2012). He is an active cardiac surgeon and he performed more than 8,000 open heart operations. Notably, he is the first surgeon performing radial artery plus internal mammary artery in CABG at University of Hong Kong in Asia (1995) and is well known for “He Classification” and “He solutions” for CABG grafts.  Apart from clinical practice, he is an active research and obtained more than 80 research grants and awards such as First Class Award, Tianjin Municipal Natural Science Award (2012), First Class Award, Prize of Science & Technology, The China Medicine Education Association (2021), exec.  He published 430 articles/reports in SCI-index international journals. He ranks in World's Top 2% Scientists (2019-2024) with Google scholar citation > 10,000 and  H-index of top 1%. He ranks world’s Top 1% in Medicine, Chemistry, Genetics and Molecular Biology. Highly-cited Chinese scholar (2024). The top 0.05% of all scholars worldwide (ScholarGPS).